Elizabeth Fyne

1.3k total citations
8 papers, 532 citations indexed

About

Elizabeth Fyne is a scholar working on Infectious Diseases, Virology and Immunology. According to data from OpenAlex, Elizabeth Fyne has authored 8 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Virology and 3 papers in Immunology. Recurrent topics in Elizabeth Fyne's work include HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (6 papers) and HIV/AIDS Research and Interventions (3 papers). Elizabeth Fyne is often cited by papers focused on HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (6 papers) and HIV/AIDS Research and Interventions (3 papers). Elizabeth Fyne collaborates with scholars based in United States. Elizabeth Fyne's co-authors include John W. Mellors, Anthony R. Cillo, John M. Coffin, Michael Piatak, Michele D. Sobolewski, Ronald J. Bosch, Dianna Koontz, Geneviève Doyon, Nicolas Sluis‐Cremer and Kelly Huber and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Elizabeth Fyne

8 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth Fyne United States 7 444 324 152 124 82 8 532
Michael J. Bale United States 13 472 1.1× 353 1.1× 159 1.0× 82 0.7× 111 1.4× 26 559
Talia M. Mota United States 11 336 0.8× 202 0.6× 183 1.2× 74 0.6× 74 0.9× 23 420
Marion Pardons United States 10 442 1.0× 228 0.7× 229 1.5× 99 0.8× 90 1.1× 13 502
Bonnie Hiener Australia 9 468 1.1× 277 0.9× 220 1.4× 74 0.6× 113 1.4× 15 525
Feiyu Hong United States 10 519 1.2× 396 1.2× 147 1.0× 60 0.5× 91 1.1× 15 567
Jason J. Coull United States 7 395 0.9× 373 1.2× 134 0.9× 192 1.5× 122 1.5× 9 603
Jennifer M. Zerbato Australia 15 495 1.1× 321 1.0× 266 1.8× 150 1.2× 143 1.7× 25 662
Victor G. Kramer Canada 10 321 0.7× 245 0.8× 110 0.7× 69 0.6× 117 1.4× 17 433
Wendy Bakeman United States 6 625 1.4× 359 1.1× 325 2.1× 108 0.9× 153 1.9× 7 753
Ann Thorkelson United States 5 525 1.2× 371 1.1× 168 1.1× 50 0.4× 99 1.2× 6 617

Countries citing papers authored by Elizabeth Fyne

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Fyne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Fyne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Fyne more than expected).

Fields of papers citing papers by Elizabeth Fyne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Fyne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Fyne. The network helps show where Elizabeth Fyne may publish in the future.

Co-authorship network of co-authors of Elizabeth Fyne

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Fyne. A scholar is included among the top collaborators of Elizabeth Fyne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Fyne. Elizabeth Fyne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
2.
Hong, Feiyu, Jana L. Jacobs, Evgenia Aga, et al.. (2018). Associations between HIV-1 DNA copy number, proviral transcriptional activity, and plasma viremia in individuals off or on suppressive antiretroviral therapy. Virology. 521. 51–57. 15 indexed citations
3.
Bui, John, Elias K. Halvas, Elizabeth Fyne, et al.. (2017). Ex vivo activation of CD4+ T-cells from donors on suppressive ART can lead to sustained production of infectious HIV-1 from a subset of infected cells. PLoS Pathogens. 13(2). e1006230–e1006230. 36 indexed citations
4.
Hong, Feiyu, Evgenia Aga, Anthony R. Cillo, et al.. (2016). Novel Assays for Measurement of Total Cell-Associated HIV-1 DNA and RNA. Journal of Clinical Microbiology. 54(4). 902–911. 83 indexed citations
5.
Bui, John, Elias K. Halvas, Elizabeth Fyne, et al.. (2015). A subset of infectious proviruses persist and expand following activation ex vivo. Journal of Virus Eradication. 1. 10–11. 1 indexed citations
6.
Cillo, Anthony R., Michele D. Sobolewski, Ronald J. Bosch, et al.. (2014). Quantification of HIV-1 latency reversal in resting CD4 + T cells from patients on suppressive antiretroviral therapy. Proceedings of the National Academy of Sciences. 111(19). 7078–7083. 181 indexed citations
7.
Cillo, Anthony R., Margaret A Bedison, Elizabeth M. Anderson, et al.. (2014). Improved Single-Copy Assays for Quantification of Persistent HIV-1 Viremia in Patients on Suppressive Antiretroviral Therapy. Journal of Clinical Microbiology. 52(11). 3944–3951. 79 indexed citations
8.
Huber, Kelly, et al.. (2011). Inhibitors of Histone Deacetylases. Journal of Biological Chemistry. 286(25). 22211–22218. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026